Terms: = Head and neck cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Staging
60 results:
1. Perioperative Durvalumab for Resectable Non-Small-Cell Lung cancer.
Heymach JV; Harpole D; Mitsudomi T; Taube JM; Galffy G; Hochmair M; Winder T; Zukov R; Garbaos G; Gao S; Kuroda H; Ostoros G; Tran TV; You J; Lee KY; Antonuzzo L; Papai-Szekely Z; Akamatsu H; Biswas B; Spira A; Crawford J; Le HT; Aperghis M; Doherty GJ; Mann H; Fouad TM; Reck M;
N Engl J Med; 2023 Nov; 389(18):1672-1684. PubMed ID: 37870974
[TBL] [Abstract] [Full Text] [Related]
2. Simultaneous Detection of Two Extracellular Vesicle Subpopulations in Saliva Assisting Tumor T staging of Oral Squamous Cell Carcinoma.
Feng J; Xiao BL; Zhang LZ; Zhang YH; Tang M; Xu CM; Chen G; Zhang ZL
Anal Chem; 2023 May; 95(19):7753-7760. PubMed ID: 37130010
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic stratification of oropharyngeal cancer patients in a betel nut chewing and low HPV area.
Lee HP; Lee CC
J Otolaryngol Head Neck Surg; 2023 Apr; 52(1):27. PubMed ID: 37081578
[TBL] [Abstract] [Full Text] [Related]
4. Nimotuzumab plus induction chemotherapy followed by radiotherapy/concurrent chemoradiotherapy plus nimotuzumab for locally advanced nasopharyngeal carcinoma: protocol of a multicentre, open-label, single-arm, prospective phase II trial.
Yuan JJ; Ding JW; Li JW; Hu RH; Gong D; Hu JL; Zhu KB; Liu Y; Ding YH; Wei JW; Zeng JL; Lu ZB; Yin WH; Ai SF; Zha GH; Zhang ZL; Zou R; Zeng L
BMJ Open; 2022 Aug; 12(8):e051594. PubMed ID: 36008072
[TBL] [Abstract] [Full Text] [Related]
5. Is there any correlation between tumor infiltrating lymphocytes and expression of egfr in squamous cell carcinoma of head and neck? A retrospective observational study.
Dasgupta S; Biswas N; Deb AR; Chakrabarti S
Indian J Pathol Microbiol; 2022; 65(2):262-267. PubMed ID: 35435357
[TBL] [Abstract] [Full Text] [Related]
6. First Clinical Results of Fluorescence Lifetime-enhanced Tumor Imaging Using Receptor-targeted Fluorescent Probes.
Pal R; Hom ME; van den Berg NS; Lwin TM; Lee YJ; Prilutskiy A; Faquin W; Yang E; Saladi SV; Varvares MA; Rosenthal EL; Kumar ATN
Clin Cancer Res; 2022 Jun; 28(11):2373-2384. PubMed ID: 35302604
[TBL] [Abstract] [Full Text] [Related]
7. The Yin and Yang of erbb4: Tumor Suppressor and Oncoprotein.
Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ
Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087
[TBL] [Abstract] [Full Text] [Related]
8. head and neck squamous cell carcinoma.
Johnson DE; Burtness B; Leemans CR; Lui VWY; Bauman JE; Grandis JR
Nat Rev Dis Primers; 2020 Nov; 6(1):92. PubMed ID: 33243986
[TBL] [Abstract] [Full Text] [Related]
9. Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update.
Devaraja K; Aggarwal S; Verma SS; Gupta SC
Life Sci; 2020 Mar; 245():117383. PubMed ID: 32007572
[TBL] [Abstract] [Full Text] [Related]
10. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-egfr Antibody) or Chemotherapy in Locally Advanced head and neck cancer.
Al-Saleh K; El-Sherify M; Safwat R; Elbasmy A; Shete J; Hussein A; Nazeeh M; Bedair A
Gulf J Oncolog; 2019 May; 1(30):6-12. PubMed ID: 31242976
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th edition.
Gurin D; Slavik M; Hermanova M; Shatokhina T; Sana J; Kazda T; Selingerova I; Ahmad P; Smilek P; Horakova Z; Hendrych M; Slampa P; Slaby O
J Oral Pathol Med; 2018 Oct; 47(9):864-872. PubMed ID: 30079604
[TBL] [Abstract] [Full Text] [Related]
12. Associations Between [
Surov A; Meyer HJ; Höhn AK; Winter K; Sabri O; Purz S
Mol Imaging Biol; 2019 Apr; 21(2):368-374. PubMed ID: 29931433
[TBL] [Abstract] [Full Text] [Related]
13. Association between clinical stage of oral cancer and expression of immunohistochemical markers.
Świątkowski W; Rahnama M; Tomaszewski T; Bigas M; Świątkowska A; Łobacz M; Wallner J
Pol Przegl Chir; 2017 Dec; 89(6):17-22. PubMed ID: 29335388
[TBL] [Abstract] [Full Text] [Related]
14. Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance.
Vincent-Chong VK; Salahshourifar I; Woo KM; Anwar A; Razali R; Gudimella R; Rahman ZA; Ismail SM; Kallarakkal TG; Ramanathan A; Wan Mustafa WM; Abraham MT; Tay KK; Zain RB
PLoS One; 2017; 12(4):e0174865. PubMed ID: 28384287
[TBL] [Abstract] [Full Text] [Related]
15. Epidermal Growth Factor Receptor (egfr) and Keratin 5 (K5): Versatile Keyplayers Defining Prognostic and Therapeutic Sub-classes of head and neck Squamous Cell Carcinomas.
Cimpean AM; Balica RA; Doros IC; Balica NC; Gaje PN; Popovici RA; Raica M
Cancer Genomics Proteomics; 2016; 13(1):75-81. PubMed ID: 26708602
[TBL] [Abstract] [Full Text] [Related]
16. Expression and prognostic influence of NF-κB and egfr in esophageal cancer.
Zhang YQ; Zhang JJ; Song HJ; Li DW
Genet Mol Res; 2015 Dec; 14(4):16819-26. PubMed ID: 26681028
[TBL] [Abstract] [Full Text] [Related]
17. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract] [Full Text] [Related]
18. An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung.
Zenali MJ; Weissferdt A; Solis LM; Ali S; Tang X; Mehran RJ; Wistuba II; Moran CA; Kalhor N
Hum Pathol; 2015 Jun; 46(6):836-42. PubMed ID: 25776025
[TBL] [Abstract] [Full Text] [Related]
19. A disintegrin and metalloproteinase 17 mRNA and protein expression in esophageal squamous cell carcinoma, as well as its clinicopathological factors and prognosis.
Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
Mol Med Rep; 2015 Feb; 11(2):961-7. PubMed ID: 25351873
[TBL] [Abstract] [Full Text] [Related]
20. A molecular prognostic model predicts esophageal squamous cell carcinoma prognosis.
Cao HH; Zheng CP; Wang SH; Wu JY; Shen JH; Xu XE; Fu JH; Wu ZY; Li EM; Xu LY
PLoS One; 2014; 9(8):e106007. PubMed ID: 25153136
[TBL] [Abstract] [Full Text] [Related]
[Next]
